JP2023175819A5 - - Google Patents
Info
- Publication number
- JP2023175819A5 JP2023175819A5 JP2023149578A JP2023149578A JP2023175819A5 JP 2023175819 A5 JP2023175819 A5 JP 2023175819A5 JP 2023149578 A JP2023149578 A JP 2023149578A JP 2023149578 A JP2023149578 A JP 2023149578A JP 2023175819 A5 JP2023175819 A5 JP 2023175819A5
- Authority
- JP
- Japan
- Prior art keywords
- regnase
- positions
- phosphorylation
- seq
- kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018108400 | 2018-06-06 | ||
| JP2018108400 | 2018-06-06 | ||
| JP2018167326 | 2018-09-06 | ||
| JP2018167326 | 2018-09-06 | ||
| JP2018229845 | 2018-12-07 | ||
| JP2018229845 | 2018-12-07 | ||
| JP2019089270 | 2019-05-09 | ||
| JP2019089270 | 2019-05-09 | ||
| PCT/JP2019/022582 WO2019235581A1 (ja) | 2018-06-06 | 2019-06-06 | Ｒｅｇｎａｓｅ－１が関与する疾患の治療および／または予防方法 |
| JP2020523181A JP7778301B2 (ja) | 2018-06-06 | 2019-06-06 | Ｒｅｇｎａｓｅ－１が関与する疾患の治療および／または予防方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523181A Division JP7778301B2 (ja) | 2018-06-06 | 2019-06-06 | Ｒｅｇｎａｓｅ－１が関与する疾患の治療および／または予防方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023175819A JP2023175819A (ja) | 2023-12-12 |
| JP2023175819A5 true JP2023175819A5 (https=) | 2026-02-05 |
Family
ID=68769816
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523181A Active JP7778301B2 (ja) | 2018-06-06 | 2019-06-06 | Ｒｅｇｎａｓｅ－１が関与する疾患の治療および／または予防方法 |
| JP2023149578A Pending JP2023175819A (ja) | 2018-06-06 | 2023-09-14 | Ｒｅｇｎａｓｅ－１が関与する疾患の治療および／または予防方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523181A Active JP7778301B2 (ja) | 2018-06-06 | 2019-06-06 | Ｒｅｇｎａｓｅ－１が関与する疾患の治療および／または予防方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20220125891A1 (https=) |
| EP (1) | EP3804759A4 (https=) |
| JP (2) | JP7778301B2 (https=) |
| WO (1) | WO2019235581A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190284553A1 (en) | 2018-03-15 | 2019-09-19 | KSQ Therapeutics, Inc. | Gene-regulating compositions and methods for improved immunotherapy |
| WO2021132329A1 (ja) * | 2019-12-24 | 2021-07-01 | 国立大学法人大阪大学 | 体脂肪低下剤および体脂肪低下作用を有する物質のスクリーニング方法 |
| CN116322716A (zh) | 2020-09-23 | 2023-06-23 | 克里斯珀医疗股份公司 | Regnase-1和/或TGFBRII被破坏的基因工程化T细胞具有改善的功能性和持久性 |
| KR102560134B1 (ko) * | 2021-04-01 | 2023-07-27 | 가톨릭대학교 산학협력단 | 세포투과성 Regnase-1 재조합 단백질 및 이를 유효성분으로 함유하는 항염증용 조성물 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
| DE69222303T2 (de) | 1991-04-30 | 1998-01-22 | Eukarion Inc | Kationisierte antikörper gegen intrazelluläre eiweisse |
| US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
| EP0646178A1 (en) | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
| AU687010B2 (en) | 1992-07-17 | 1998-02-19 | Dana-Farber Cancer Institute | Method of intracellular binding of target molecules |
| US5910486A (en) | 1994-09-06 | 1999-06-08 | Uab Research Foundation | Methods for modulating protein function in cells using, intracellular antibody homologues |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US7892730B2 (en) * | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
| US20030104402A1 (en) | 2001-01-23 | 2003-06-05 | University Of Rochester | Methods of producing or identifying intrabodies in eukaryotic cells |
| WO2003077945A1 (en) | 2002-03-14 | 2003-09-25 | Medical Research Council | Intracellular antibodies |
| US20070142288A1 (en) * | 2005-12-20 | 2007-06-21 | Pappachan Kolattukudy | Isolated MCPIP and methods of use |
| US20130195882A1 (en) * | 2012-01-31 | 2013-08-01 | Pappachan Kolattukudy | Mcpip protection against osteoclast production |
| JP5605602B2 (ja) * | 2007-03-26 | 2014-10-15 | 国立大学法人 東京大学 | 環状ペプチド化合物の合成方法 |
| JPWO2010098429A1 (ja) * | 2009-02-27 | 2012-09-06 | 国立大学法人大阪大学 | 免疫アジュバント組成物、及びその利用 |
| JP5818237B2 (ja) | 2010-09-09 | 2015-11-18 | 国立大学法人 東京大学 | Ｎ−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法 |
| TW202446781A (zh) | 2011-12-28 | 2024-12-01 | 日商中外製藥股份有限公司 | 胜肽化合物之製造方法 |
| CN105658230B (zh) | 2013-08-29 | 2020-04-21 | 希望之城 | 细胞穿透缀合物及其使用方法 |
| WO2016013870A1 (ko) | 2014-07-22 | 2016-01-28 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 항체를 세포막을 투과하여 세포질에 위치시키는 방법 및 그의 이용 |
| EP4166664A1 (en) * | 2015-03-13 | 2023-04-19 | Chugai Seiyaku Kabushiki Kaisha | Modified aminoacyl-trna synthetase and use thereof |
| EP3655007A4 (en) * | 2017-07-21 | 2021-04-28 | The Cleveland Clinic Foundation | SBE APTAMERE FOR THE TREATMENT OF IL-17A DISEASES AND DISEASES |
| US11179412B2 (en) * | 2017-12-04 | 2021-11-23 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods of treating conditions involving elevated inflammatory response |
| WO2019182055A1 (ja) * | 2018-03-22 | 2019-09-26 | 国立大学法人京都大学 | 炎症抑制用の組成物 |
| WO2020032160A1 (ja) * | 2018-08-09 | 2020-02-13 | 国立大学法人大阪大学 | 炎症性腸疾患治療薬およびそのスクリーニング方法 |
-
2019
- 2019-06-06 US US15/734,885 patent/US20220125891A1/en not_active Abandoned
- 2019-06-06 WO PCT/JP2019/022582 patent/WO2019235581A1/ja not_active Ceased
- 2019-06-06 JP JP2020523181A patent/JP7778301B2/ja active Active
- 2019-06-06 EP EP19814696.1A patent/EP3804759A4/en active Pending
-
2023
- 2023-09-14 JP JP2023149578A patent/JP2023175819A/ja active Pending
-
2024
- 2024-06-25 US US18/753,584 patent/US20250018014A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023175819A5 (https=) | ||
| Lockhart et al. | Tools for detecting a “superbug”: updates on Candida auris testing | |
| Zapatka et al. | The landscape of viral associations in human cancers | |
| van Diepeningen et al. | Diagnosis of Fusarium infections: approaches to identification by the clinical mycology laboratory | |
| Pfarr et al. | High‐throughput diagnostic profiling of clinically actionable gene fusions in lung cancer | |
| McDonald et al. | Pneumocystis jirovecii pneumonia in people living with HIV: a review | |
| Sellarés et al. | Molecular diagnosis of antibody‐mediated rejection in human kidney transplants | |
| Nicot et al. | Diversity of hepatitis E virus genotype 3 | |
| JP2012508865A5 (https=) | ||
| CA2673296A1 (en) | Improved assay for immunosuppressant drugs | |
| JP2006502416A5 (https=) | ||
| JP2008509673A5 (https=) | ||
| CN105223364A (zh) | 血清shbg蛋白作为肺结核病人血清标志物及其应用 | |
| Hanson et al. | Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients | |
| Royer et al. | Comparison of metagenomic and traditional methods for diagnosis of E. coli enteric infections | |
| Issing et al. | Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status | |
| Katz-Greenberg et al. | Post-transplant lymphoproliferative disorders (PTLD)-from clinical to metabolic profiles-a single center experience and review of literature | |
| Axell-House et al. | LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium | |
| CN102435748B (zh) | 一种双抗夹心酶联免疫检测试剂盒及其制备方法 | |
| Havaleshko et al. | Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer | |
| CN103288963B (zh) | 吉他霉素残留检测用单克隆抗体及制备方法和应用 | |
| Tanca et al. | High throughput genomic and proteomic technologies in the fight against infectious diseases | |
| Tsukamoto et al. | Lung pathology of mutually exclusive co-infection with SARS-CoV-2 and Streptococcus pneumoniae | |
| KR20090131468A (ko) | 노로바이러스 검출을 위한 프라이머 및 상기 프라이머를포함하는 노로바이러스 유전자 검출 및 유전자형 동정방법 | |
| EP0354808A2 (en) | Polypeptide-induced monoclonal receptors to protein ligands |